I think I will take the advice of some of the professionals in the industry regarding the potential for the device. While I do agree at some stage in the US we will need to conduct a RCT but I think the results from the RCT will be consistent with what they have been getting in the smaller PanCo study.
Dr Zarni Win, Consultant Radiologist and Nuclear Medicine Physician at The London Clinic, said: “I am particularly excited about this new therapy, as it now offers a much higher chance for pancreatic cancer patients with locally advanced disease to undergo curative surgery following OncoSil therapy, compared to a more pessimistic outcome with conventional treatment.”
Ann: Half Yearly Report and Accounts, page-50
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $19.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $24.67K | 4.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1800000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 16832747 | 23 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |